氯贝丁酯

药物禁忌症

【禁忌症】: 1.对本药过敏者。; 2.严重肝功能不全或原发性胆汁性肝硬化患者。; 3.严重肾功能不全者。; 4.妊娠期妇女。; 5.哺乳期妇女。

【参考文献】: 1.说明书-Atromid-S(R), clofibrate(Ayerst Laboratories, Philadelphia, PA); 2.说明书-Atromid-S(R), clofibrate(Wyeth-Ayerst Laboratories, Philadelphia, PA); 3.说明书-Atromid-S(R), clofibrate(Wyeth-Ayerst, Philadelphia, PA); 4.说明书-Baycol(R), cerivastatin sodium(Bayer Corporation, West Haven, CT); 5.说明书-COLCRYS(TM) oral tablets, colchicine oral tablets(Mutual Pharmaceutical Company, Philadelphia, PA); 6.说明书-Lescol(R), fluvastatin(Novartis Pharmaceuticals Corporation, East Hanover, NJ); 7.说明书-Lipitor(TM), atorvastatin(Parke-Davis, Morris Plains, NJ); 8.说明书-Mevacor(R), lovastatin(Merck & Co., Inc., Whitehouse Station, NJ); 9.说明书-Priftin(R), rifapentine tablets(Aventis Pharmaceuticals, Inc., Kansas City, MO); 10.说明书-Rifadin(R), rifampin(Hoechst Marion Roussel, Kansas City, MO); 11.说明书-ZETIA(R) oral tablets, ezetimibe oral tablets(Merck/Schering-Plough Pharmaceuticals, North Wales, PA); 12.说明书-氯贝丁酯胶囊; 13.文献资料-Acta Derm Venereo,1994; 14.文献资料-Br J Clin Pharmacol,1984; 15.文献资料-Br Med J,1979; 16.文献资料-Clin Pharmacol Ther,1975; 17.文献资料-Eur J Clin Pharmacol,1989; 18.文献资料-Gastroenterology,1975; 19.文献资料-Isr J Med Sci,1984; 20.文献资料-J Am Acad Dermatol,1988; 21.文献资料-JAMA,1973; 22.文献资料-JAMA,1975; 23.文献资料-JAMA,1982; 24.文献资料-Lancet,1973; 25.文献资料-N Engl J Med,1976; 26.文献资料-N Engl J Med,1977; 27.文献资料-Nephron,1980; 28.文献资料-Panminerva Med,1984; 29.文献资料-Tek Arkh,1977; 30.文献资料-Therapie,1974; 31.国家药典委员会.中华人民共和国药典临床用药须知:化学药和生物制品卷.2005年版.北京:人民卫生出版社,2005.228; 32.陈新谦,金有豫,汤光.新编药物学.第17版.北京:人民卫生出版社,2011.417,565,590; 点击展开全部文献

禁忌症
参考文献

老人用药

【安全级别及用药方案】: 安全老人用药遵循具体用法用量。

【参考文献】: 1.说明书-Atromid-S(R), clofibrate(Ayerst Laboratories, Philadelphia, PA); 2.说明书-Atromid-S(R), clofibrate(Wyeth-Ayerst Laboratories, Philadelphia, PA); 3.说明书-Atromid-S(R), clofibrate(Wyeth-Ayerst, Philadelphia, PA); 4.说明书-Baycol(R), cerivastatin sodium(Bayer Corporation, West Haven, CT); 5.说明书-COLCRYS(TM) oral tablets, colchicine oral tablets(Mutual Pharmaceutical Company, Philadelphia, PA); 6.说明书-Lescol(R), fluvastatin(Novartis Pharmaceuticals Corporation, East Hanover, NJ); 7.说明书-Lipitor(TM), atorvastatin(Parke-Davis, Morris Plains, NJ); 8.说明书-Mevacor(R), lovastatin. Merck & Co., Inc.(, Whitehouse Station, NJ, 2002); 9.说明书-Priftin(R), rifapentine tablets(Aventis Pharmaceuticals, Inc., Kansas City, MO); 10.说明书-Rifadin(R), rifampin(Hoechst Marion Roussel, Kansas City, MO); 11.说明书-ZETIA(R) oral tablets, ezetimibe oral tablets(Merck/Schering-Plough Pharmaceuticals, North Wales, PA); 12.说明书-氯贝丁酯胶囊; 13.文献资料-Acta Derm Venereo,1994; 14.文献资料-Br J Clin Pharmacol,1984; 15.文献资料-Br Med J,1979; 16.文献资料-Clin Pharmacol Ther,1975; 17.文献资料-Eur J Clin Pharmacol,1989; 18.文献资料-Gastroenterology,1975; 19.文献资料-Isr J Med Sci,1984; 20.文献资料-J Am Acad Dermatol,1988; 21.文献资料-JAMA,1973; 22.文献资料-JAMA,1975; 23.文献资料-JAMA,1982; 24.文献资料-Lancet,1973; 25.文献资料-N Engl J Med,1976; 26.文献资料-N Engl J Med,1977; 27.文献资料-Nephron,1980; 28.文献资料-Panminerva Med,1984; 29.文献资料-Tek Arkh,1977; 30.文献资料-Therapie,1974; 31.国家药典委员会.中华人民共和国药典临床用药须知:化学药和生物制品卷.2005年版.北京:人民卫生出版社,2005.228; 32.陈新谦,金有豫,汤光.新编药物学.第17版.北京:人民卫生出版社,2011.417,565,590; 点击展开全部文献

安全级别及用药方案
参考文献

儿童用药

【安全级别及用药方案】: 慎用本药尚未对儿童用药给予特殊说明，儿童用药剂量一般根据年龄和体重来计算，建议用法：1岁以内儿童给予成人剂量*0.01*（月龄+3）；1岁以上儿童给予成人剂量*0.05*（年龄+2）。

【参考文献】: 1.说明书-Atromid-S(R), clofibrate(Ayerst Laboratories, Philadelphia, PA); 2.说明书-Atromid-S(R), clofibrate(Wyeth-Ayerst Laboratories, Philadelphia, PA); 3.说明书-Atromid-S(R), clofibrate(Wyeth-Ayerst, Philadelphia, PA); 4.说明书-Baycol(R), cerivastatin sodium(Bayer Corporation, West Haven, CT); 5.说明书-COLCRYS(TM) oral tablets, colchicine oral tablets(Mutual Pharmaceutical Company, Philadelphia, PA); 6.说明书-Lescol(R), fluvastatin(Novartis Pharmaceuticals Corporation, East Hanover, NJ); 7.说明书-Lipitor(TM), atorvastatin(Parke-Davis, Morris Plains, NJ); 8.说明书-Mevacor(R), lovastatin. Merck & Co., Inc.(, Whitehouse Station, NJ, 2002); 9.说明书-Priftin(R), rifapentine tablets(Aventis Pharmaceuticals, Inc., Kansas City, MO); 10.说明书-Rifadin(R), rifampin(Hoechst Marion Roussel, Kansas City, MO); 11.说明书-ZETIA(R) oral tablets, ezetimibe oral tablets(Merck/Schering-Plough Pharmaceuticals, North Wales, PA); 12.说明书-氯贝丁酯胶囊; 13.文献资料-Acta Derm Venereo,1994; 14.文献资料-Br J Clin Pharmacol,1984; 15.文献资料-Br Med J,1979; 16.文献资料-Clin Pharmacol Ther,1975; 17.文献资料-Eur J Clin Pharmacol,1989; 18.文献资料-Gastroenterology,1975; 19.文献资料-Isr J Med Sci,1984; 20.文献资料-J Am Acad Dermatol,1988; 21.文献资料-JAMA,1973; 22.文献资料-JAMA,1975; 23.文献资料-JAMA,1982; 24.文献资料-Lancet,1973; 25.文献资料-N Engl J Med,1976; 26.文献资料-N Engl J Med,1977; 27.文献资料-Nephron,1980; 28.文献资料-Panminerva Med,1984; 29.文献资料-Tek Arkh,1977; 30.文献资料-Therapie,1974; 31.国家药典委员会.中华人民共和国药典临床用药须知:化学药和生物制品卷.2005年版.北京:人民卫生出版社,2005.228; 32.陈新谦,金有豫,汤光.新编药物学.第17版.北京:人民卫生出版社,2011.417,565,590; 点击展开全部文献

安全级别及用药方案
参考文献